The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells
Combination Index (CI) analysis suggested that MBIC and doxorubicin synergistically inhibited up to 97% of cell proliferation in ER+/PR+ MCF-7 and triple negative MDA-MB-231 breast cancer cell lines. Moreover, treatment of the breast cancer cells with the combined drugs resulted in lower IC50 values...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Published: |
PeerJ
2018
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/21928/ https://doi.org/10.7717/peerj.5577 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|